Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations |
---|---|
6/30/2025 | $ -60.19M |
3/31/2025 | $ -58.95M |
12/31/2024 | $ -64.85M |
9/30/2024 | $ -71.83M |
6/30/2024 | $ -72.88M |
3/31/2024 | $ -77.93M |
12/31/2023 | $ -85.94M |
9/30/2023 | $ -85.63M |
6/30/2023 | $ -82.54M |
3/31/2023 | $ -83.28M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Dec 31, 2023
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.27K |
---|---|
min | $ -406M |
max | $ 506.5M |
average | $ 57.94M |
median | $ 10.78M |
std | $ 141.66M |